Cite
MLA Citation
Gerard Morton et al.. “Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy.” Radiotherapy and oncology, vol. 146, 2020, pp. 90–96. http://access.bl.uk/ark:/81055/vdc_100104103262.0x00004a